Aprepitant


IVEMEND 150 mg powder for solution for infusion

IVEMEND contains the active substance fosaprepitant which is converted to aprepitant in your body. IVEMEND is used in combination with other medicines to prevent nausea and vomiting caused by chemotherapy (cancer treatment) in adults. Mehr

Producer: Merck Sharp & Dohme Ltd.

Therapeutic group: Antiemetics and antinauseants


IVEMEND 115 mg powder for solution for infusion

IVEMEND contains the active substance fosaprepitant which is converted to aprepitant in your body. IVEMEND is used in combination with other medicines to prevent nausea and vomiting caused by chemotherapy (cancer treatment) in adults. Mehr

Producer: Merck Sharp & Dohme Ltd.

Therapeutic group: Antiemetics and antinauseants


EMEND 125 mg hard capsulesEMEND 80 mg hard capsules

EMEND is used in combination with other medicines to prevent nausea and vomiting caused by chemotherapy (cancer treatment). Mehr

Producer: Merck Sharp & Dohme Ltd.

Therapeutic group: Antiemetics and antinauseants


EMEND 125 mg hard capsules

EMEND is used in combination with other medicines to prevent nausea and vomiting caused by chemotherapy (cancer treatment). Mehr

Producer: Merck Sharp & Dohme Ltd.

Therapeutic group: Antiemetics and antinauseants


EMEND 80 mg hard capsules

EMEND is used in combination with other medicines to prevent nausea and vomiting caused by chemotherapy (cancer treatment). Mehr

Producer: Merck Sharp & Dohme Ltd.

Therapeutic group: Antiemetics and antinauseants


EMEND 40 mg hard capsules

EMEND is used to prevent nausea and vomiting after surgery. Mehr

Producer: Merck Sharp & Dohme Ltd.

Therapeutic group: Antiemetics and antinauseants


Cookies help us deliver our services. By using our services, you agree to our use of cookies. OK